Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide

Neuroscience Research

Volumn 45, Issue 1, 2003, Pages 117-127

  Melo, Joana Barbosa ^a   Agostinho, Paula ^a   Oliveira, Catarina Resende ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Acetylcholinesterase; Beta amyloid; Nitric oxide synthase; Oxidative stress; Retinal cells

Indexed keywords

7 NITROINDAZOLE; ACETYLCHOLINE; ACETYLCHOLINESTERASE; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME DEGRADATION; LIPID PEROXIDATION; MEMORY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA CELL;

ACETYLCHOLINESTERASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; CALCIUM; CELLS, CULTURED; CHICK EMBRYO; LIPID PEROXIDATION; NEURONS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RETINA;

EID: 0037219182     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(02)00201-8     Document Type: Article

References (63)

1. Abe K., Saito H. Both oxidative stress-dependent and independent effects of amyloid beta protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction assay. Brain Res. 830:1999;146-154.
2. 3H]GABA in cultured chick retina cells. Brain Res. 655:1994;213-221.
3. 2+ channels in cultured retinal cells. Neurosci. Res. 27:1997;323-334.
4. 2+-induced oxidative stress. J. Neurochem. 67:1996;1153-1163.
5. Alvarez A., Alarcón R., Opazo C., Campos E.O., Muñoz F.J., Caldéron F.H., Dajas F., Gentry M.K., Doctor B.P., De Mello F.G., Inestrosa N.C. Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J. Neurosci. 18:1998;3213-3223.
6. Alvarez A., Opazo C., Alarcón R., Garrido J., Inestrosa N.C. Acetylcholinesterase promotes the aggregation of amyloid-β peptide fragments by forming a complex with growing fibrils. J. Mol. Biol. 272:1997;348-361.
7. Atack J.R., Perry E.K., Bonham J.R., Perry R.H., Tomlinson B.E., Blessed G., Fairbairn A. Molecular forms of acetylcholinesterase in senile dementia of Alzheimer's type: selective loss of the intermediate (10S) form. Neurosci. Lett. 40:1983;199-204.
8. Behl C., Davis J.B., Cole G.M., Shubert D. Vitamin E protects nerve cells from amyloid β-protein toxicity. Biochem. Biophys. Res. Commun. 186:1992;944-950.
9. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β-protein toxicity. Cell. 77:1994;817-827.
10. Bergmeyer H.U., Brent E. UV-assay with pyruvate and NADH. Bergmeyer H.U. Methods of Enzymatic Analysis. 1974;574-579 Academic Press, New York.
11. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52:1967;302-310.
12. Bus A.I., Huang X., Fairlie D.P. The possible origin of free radicals from amyloid β-peptides in Alzheimer's disease. Neurobiol. Aging. 20:1999;335-337.
13. Butterfield D.A., Hensley K., Harris M., Mattson M., Carney J. β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:1994;710-715.
14. Cardoso S.M., Pereira C., Oliveira C.R. Mitochondrial function is differently affected upon oxidative stress. Free Radical Biology & Medicine. 26:1999;3-13.
15. Carroll R.T., Lust M.R., Emmerling M.R. Beta-amyloid levels predict cholinesterase activity in human cerebrospinal fluid. Neuroreport. 10:1999;127-130.
16. Carvalho A.L., Duarte C.B., Faro C.J., Carvalho A.P., Pires E.V. Calcium influx through AMPA receptors and through calcium channels is regulated by protein kinase C in cultured retina amacrine-like cells. J. Neurochem. 70:1998;2112-2119.
17. Cathcart R., Schwiers E., Ames B.N. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. Anal. Biochem. 134:1983;111-116.
18. Dobretsov G.E., Borschievskaya T.A., Petrov V.A., Vladimirov Y.A. The increase of phospholipid bilayer rigidity after lipid peroxidation. FEBS Lett. 84:1977;125-128.
19. Dutrait N., Culcasi M., Cazevieille C., Pietri S., Tordo P., Bonne C., Muller A. Calcium-dependent free radical generation in cultured retinal neurons induced by kainate. Neurosci. Lett. 198:1995;13-16.
20. Ekinci F.J., Linsley M.-D., Shea T.B. β-Amyloid-induced calcium influx induces apoptosis in culture by oxidative stress rather than tau phosphorylation. Mol. Brain Res. 76:2000;389-395.
21. Ekinci F.J., Malik K.M., Shea T.B. Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to β-amyloid. MAP kinase mediates β-amyloid-induced neurodegeneration. J. Biol. Chem. 274:1999;30322-30327.
22. Ellman G.L., Courtney K.D., Anders V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
23. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad. Biol. Med. 11:1991;81-128.
24. Fraser S.P., Suh Y.-H., Chong Y.H., Djamgoz M.B.A. Membrane currents induced in Xenopus oocytes by the C-terminal fragment of the β-amyloid precursor protein. J. Neurochem. 66:1996;2034-2040.
25. Geula C., Mesulam M.-M. Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease. Terry R.D., Katzman R., Bick K.L. Alzheimer Disease. 1994;263-291 Raven press, New York.
26. Gray C.W., Pattel A.J. Neurodegeneration mediated by glutamate and β-amyloid peptide: a comparison and possible interaction. Brain Res. 691:1995;169-179.
27. Harkany T., Mulder J., Sasvári M., Ábrahám I., Kónya C., Zarándi M., Penke B., Luiten P.G.M., Nyakas C. N-methyl-D-Aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against β-amyloid neurotoxicity. Neurobiol. Dis. 6:1999;109-121.
28. Huang X., Atwood C.S., Hartshorn M.A., Multhaup G., Golldstein L.E., Scarpa R.C., Cuajungco M.P., Gray D.N., Lim J., Moir R.D., Tanzi R.E., Bush A.I. The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 38:1999;7609-7616.
29. Hyman B.T., Marzloff K., Arriagada P.V. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J. Neuropathol. Exp. Neurol. 52:1993;594-600.
30. Inestrosa N.C., Alvarez A., Pérez C.A., Moreno R.D., Vicente M., Linker C., Casanueva O.I., Soto C., Garrido J. Acetylcholinesterase accelerates assembly of amyloid β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron. 16:1996;881-891.
31. Kang J., Lenmaire H.-G., Unterbeck A., Salbaum M.N., Masters C.L., Grzeschik K.-H., Multhaup G., Beyreuther K., Mueller-Hill B. The precursor protein of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature. 325:1987;733-736.
32. Kasa P., Papp H., Kovacs I., Forgon M., Penke B., Yamaguchi H. Human amyloid-β 1-42 applied in vivo inhibits the fast axonal transport of proteins in the sciatic nerve of rat. Neurosci. Lett. 278:2000;117-119.
33. Kasa P., Rakonczany Z., Gulya K. The cholinergic system in Alzheimer's disease. Prog. Neurobiol. 52:1997;511-535.
34. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.-W., Shaltiel S., Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186:1990;464-478.
35. Law A., Gauthier S., Quirion R. Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity. Br. J. Pharmacol. 133:2001;1114-1124.
36. Law A., Gauthier S., Quirion R. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res. Rev. 1:2001;73-96.
37. Liu Y., Schubert D. Cytotoxic amyloid peptides inhibit cellular3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis. J Neurochem. 69:1997;2285-2293.
38. Luth H., Holzer M., Gartner U., Staufenbiel M., Arendt T. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. Brain Res. 913:2001;57-67.
39. Mark R.J., Lovell M.A., Markesberry W.R., Uchida K., Mattson M.P. A role for 4-hidroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68:1997;255-264.
40. Mark R.J., Pang Z., Geddes J.W., Uchida K., Mattson M.P. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17:1997;1046-1054.
41. Mattson M.P. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 21:1998;53-57.
42. Mattson M.P., Barger S.W., Begley J.G., Mark R.J. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46:1995;187-216.
43. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;379-389.
44. Massoulié J., Pezzementi L., Bon S., Krejci E., Vallette F.M. Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 41:1993;31-91.
45. 3H]acetylcholine release in retinal neurons. Involvement of metabolic dysfunction. Amyloid, in press.
46. Morán M.A., Mufson E.J., Gómez-Ramos P. Colocalization of cholinesterases with β amyloid protein in aged and Alzheimer's brains. Acta Neuropathol. 85:1993;362-369.
47. Mosmann T. Rapid colorimetric assay for cellular growth and survival. J. Immunol. Methods. 65:1983;55-63.
48. Pereira C., Santos M.S., Oliveira C. Involvement of oxidative stress on the impairment of energy metabolism induced by Aβ peptides on PC12 cells: protection by antioxidants. Neurobiol. Dis. 6:1999;209-219.
49. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.J., Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of protein assembly state. J. Neurosci. 13:1993;1676-1687.
50. Prendergast F.G., Haugland R.P., Callahan P.J. 1-[4-(trimethylamino)phenyl-6-phrnylhexa-1,3,5-triene: synthesis, fluorescence properties, and use as a fluorescence probe of lipid bilayers. Biochemistry. 20:1981;7333-7338.
51. Rego A.C., Oliveira C.R. Dual effect of lipid peroxidation on the membrane order of retinal cells in culture. Arch. Biochem. Biophys. 321:1995;127-136.
52. Rego A.C., Santos M.S., Proença M.T., Oliveira C.R. Influence of vitamin E succinate on retinal cell survival. Toxicology. 128:1998;113-124.
53. 3H]Acetylcholine release from cultured amacrine-like neurons by adenosine A1 receptors. J. Neurochem. 71:1998;1086-1094.
54. Sberna G., Saez-Valero J., Beyreuther K., Masters C.L., Small D.H. The amyloid beta-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J. Neurochem. 69:1997;1177-1184.
55. Sberna G., Saez-Valero J., Li Q.X., Czech C., Beyreuther K., Masters C.L., McLean C.A., Small D.H. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease. J. Neurochem. 71:1998;723-731.
56. Sedmak J.J., Grossero S.E. A rapid sensitive and versatile assay for protein using Coomassie Brilliant Blue G250. Anal. Biochem. 79:1977;544-552.
57. Shinitzky M., Barenholz Y. Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim. Biophys. Acta. 555:1978;367-394.
58. Tanzi R.E., McClatchey A.I., Lamperti E.D., Villa-Komaroff L.T., Gusella J.F., Neve R.L. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature. 331:1988;528-530.
59. Tran, M.H., Yamada, K., Olariu, A., Mizuno, M., Ren, X.H., Nabeshima, T., 2001. Amyloid β-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. FASEB J. 10.1096/fj.00-0719fje.
60. Ulrich J., Meier-Ruge W., Probst A., Meier E., Ipsen S. Senile plaques: staining for acetylcholinesterase and A4 protein: a comparative study in the hippocampus and entorhinal cortex. Acta Neuropathol. 80:1990;624-628.
61. Van Blitterswijk W.J., Van Hoeven R.P., Van der Meer B.W. Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. Biochim. Biophys. Acta. 644:1981;323-332.
62. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.
63. Zhu Y.J., Lin H., Lal R. Fresh and nonfibrillar amyloid β protein (1-40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AβP-channel-mediated cellular toxicity. FASEB J. 14:2000;1244-1254.